Revolution Medicines to Participate in Cowen 2nd Annual Virtual Oncology Innovation Summit

NEXT STORY
Agenus to Host Conference Call to Discuss Global Licensing Agreement with Bristol Myers Squibb for Agenus’ Anti-TIGIT Bispecific Antibody Program
PREV STORY
Global Facial Tissues Markets Report 2021-2030 Featuring Kimberly-Clark, Procter and Gamble, APP, Hengan, Vinda, C&S PAPER, Metsa Tissue, WEPA, Cascades and KP Tissue
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BridgeBio Pharma’s QED Therapeutics Receives Fast Track Designation for Infigratinib in Adults with First-Line Advanced or Metastatic Cholangiocarcinoma and Orphan Drug Designation for Infigratinib for Treatment of Cholangiocarcinoma

author_avatar
NASDAQ Market News

Mustang Bio Announces Phase 1 Clinical Trial Evaluating MB-105 for Prostate Stem Cell Antigen-Positive Castration-Resistant Prostate Cancer Enrolling Patients at City of Hope

author_avatar
NASDAQ Market News

MDxHealth (R) : MDxHealth annonce la présentation des données positives de SelectMDx et de ConfirmMDx dans le diagnostic du cancer de la prostate

author_avatar
NASDAQ Market News